Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
18:56:53 EDT Fri 18 Jul 2025
Enter Symbol
or Name
USA
CA



C:DTC - Defence Therapeutics Inc. - Class A Common Shares - https://defencetherapeutics.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
DTC - C  14.50.63·0.705.00.67+0.034.720.813120.64  0.67  0.641.66  0.4815:39:27Jul 1415 min RT 2¢
CSE - C14.50.63·0.705.00.648.6540.64  0.64  0.641.66  0.4813:59:3915 min
Omega - O 0.643.5220.64  0.64  0.6409:38:0215 min
CX2 - H 0.67+0.034.78.5550.64  0.67  0.6415:39:2715 min
TriAct - M 0.640.201    15 min

Recent Trades - Last 10 of 12
Time ETExPriceChangeVolumeBuyerSellerMarkers
15:39:27H0.670.031,50080 National Bank1 AnonymousK
15:37:14M0.670.0315080 National Bank80 National BankE
13:59:39C0.63-0.0130036 Latimer19 DesjardinsE
13:39:32C0.63-0.0130036 Latimer19 DesjardinsE
10:33:20H0.670.0350080 National Bank1 AnonymousK
10:33:20H0.670.033,00080 National Bank1 AnonymousK
09:38:12C0.64 1,0001 Anonymous1 AnonymousK
09:38:02O0.64 1,5001 Anonymous1 AnonymousK
09:38:02O0.64 2,0001 Anonymous1 AnonymousK
09:38:02H0.64 1,5001 Anonymous1 AnonymousK

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2025-07-14 16:19C:DTC0.66News ReleaseDefence continues Accum ADC, radiopharma programs
2025-06-09 10:20C:DTC0.82News ReleaseDefence receives USPTO allowance for patent application
2025-06-02 11:18C:DTC0.76News ReleaseDefence Therapeutics opens first U.S. laboratory
2025-05-28 03:16C:DTC0.87News ReleaseDefence Therapeutics to Attend Bio International Convention in Boston, June 2025
2025-05-23 16:17C:DTC0.85SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2025-05-23 16:17C:DTC0.85SEDAR Interim MD & ASEDAR Interim MD & A
2025-04-08 09:27C:DTC0.90News ReleaseDefence to study Accum in combination with actinium-225
2025-03-26 11:14C:DTC1.07News ReleaseDefence Therapeutics appoints Theodorou as COO
2025-02-25 18:12C:DTC0.99SEDAR Interim MD & ASEDAR Interim MD & A
2025-02-25 18:07C:DTC0.99SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2025-01-31 18:39C:DTC1.02News ReleaseDefence Therapeutics closes second tranche of financing
2025-01-10 17:23C:DTC0.65News ReleaseDefence closes $300,000 first tranche of placement
2025-01-06 10:38C:DTC0.65News ReleaseDefence talks patent allowances, applications
2024-12-31 17:28C:DTC0.66News ReleaseDefence Therapeutics arranges $4.2-million placement
2024-12-20 10:09C:DTC0.52News ReleaseDefence Therapeutics appoints Theodorou as director
2024-12-03 03:57C:DTC0.52News ReleaseDefence to hold AGM Dec. 12
2024-11-29 18:26C:DTC0.55News ReleaseDefence to license Accum to pharma, biotech companies
2024-11-25 09:57C:DTC0.52News ReleaseDefence appoints Parisotto as chief scientific officer
2024-11-22 19:10C:DTC0.52News ReleaseDefence Therapeutics closes $1.47M debenture offering
2024-11-14 19:44C:DTC0.60News ReleaseDefence to replace debentures with new debentures